Pseudomonas aeruginosa
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
MICROBIOLOGY
- Gram-negative non-fermenting, motile bacillus [Fig 1]; known for blue-green pus due to pyocyanin and pyoverdin pigments.
- Non-fastidious organism; it can inhabit a variety of environments including soil and water (hot tubs, sinks, water faucets, respirators, disinfectants, and contact lens cleaning solutions).
- Grows on a wide variety of media. Clinical isolates usually render smooth colonies on plates [Fig 2].
- Produces biofilm, toxins and proteases.
- Drug resistance mechanisms include multiple pathways: chromosomal and inducible beta-lactamases, active efflux pumps, acquired genes and plasmid-mediated ESBLs (TEM, SHV, CTX-M), and altered permeability.[11]
- Carbapenem resistance mechanisms include:
- Loss of outer membrane porin D (OprD) results in resistance to carbapenems, specifically imipenem.[14]
- The combined loss of OprD in combination with another mechanism, i.e., overexpression of AmpC beta-lactamase OR overexpression of efflux pumps, is a major determinant of resistance to carbapenems.[10]
- Production of carbapenemases, esp. Ambler class B metallo-beta-lactamases (NDM, VIM, IMP).[3]
- Clinical utility of rapid molecular diagnostic platforms to detect genotype resistance to beta-lactam/beta-lactamase inhibitor combinations is limited by the complexity of nontested determinants of beta-lactam resistance, such as OprD changes and drug efflux systems.[6]
- Carbapenem resistance mechanisms include:
-- To view the remaining sections of this topic, please log in or purchase a subscription --
MICROBIOLOGY
- Gram-negative non-fermenting, motile bacillus [Fig 1]; known for blue-green pus due to pyocyanin and pyoverdin pigments.
- Non-fastidious organism; it can inhabit a variety of environments including soil and water (hot tubs, sinks, water faucets, respirators, disinfectants, and contact lens cleaning solutions).
- Grows on a wide variety of media. Clinical isolates usually render smooth colonies on plates [Fig 2].
- Produces biofilm, toxins and proteases.
- Drug resistance mechanisms include multiple pathways: chromosomal and inducible beta-lactamases, active efflux pumps, acquired genes and plasmid-mediated ESBLs (TEM, SHV, CTX-M), and altered permeability.[11]
- Carbapenem resistance mechanisms include:
- Loss of outer membrane porin D (OprD) results in resistance to carbapenems, specifically imipenem.[14]
- The combined loss of OprD in combination with another mechanism, i.e., overexpression of AmpC beta-lactamase OR overexpression of efflux pumps, is a major determinant of resistance to carbapenems.[10]
- Production of carbapenemases, esp. Ambler class B metallo-beta-lactamases (NDM, VIM, IMP).[3]
- Clinical utility of rapid molecular diagnostic platforms to detect genotype resistance to beta-lactam/beta-lactamase inhibitor combinations is limited by the complexity of nontested determinants of beta-lactam resistance, such as OprD changes and drug efflux systems.[6]
- Carbapenem resistance mechanisms include:
There's more to see -- the rest of this entry is available only to subscribers.